Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH)
Open Access
- 7 June 2024
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (9) , 914.e1-914.e8
Abstract
No abstract availableKeywords
Funding Information
- Institute for Scientific Research, Boston College
- Jazz Pharmaceuticals
This publication has 39 references indexed in Scilit:
- Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeTransplantation and Cellular Therapy, 2019
- Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantationAnnals of Hematology, 2019
- Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell TransplantTransplantation and Cellular Therapy, 2018
- Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolitesPediatric Blood & Cancer, 2017
- Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2015
- Are Alternative Donors Really Still “Alternative?”Transplantation and Cellular Therapy, 2014
- The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last DecadeTransplantation and Cellular Therapy, 2011
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeTransplantation and Cellular Therapy, 2010
- the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009Hepatology, 2010
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008